Anil K. Malhotra
Anil K. Malhotra is the Director of Psychiatry Research at the Zucker Hillside Hospital in Glen Oaks, NY, and a Professor of psychiatry at the Albert Einstein College of Medicine (AECOM) in the Bronx, NY. Dr. Malhotra completed his undergraduate studies at Cornell University, NY, USA, in 1985 and received his M.D. degree from Wake Forest University, NC, USA, in 1989. After residency training in psychiatry at Georgetown University, he completed a research fellowship at the National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH). He developed a research program in pharmacogenetics at the NIMH and was appointed as the Chief of the Unit of Pharmacogenetics in the Experimental Therapeutics Branch in 1996. In 1998, Dr. Malhotra moved to the Zucker Hillside Hospital and AECOM and developed an internationally recognized molecular genetics program focused on the major neuropsychiatric disorders. His research group focuses on identifying the biological underpinnings of schizophrenia and the mechanism of action of antipsychotic drugs. His group has identified a number of genes associated with increased risk for the disorder, determined their relationship with important clinical manifestations of illness, including cognitive impairment, and begun to examine the role of genetic factors in predicting individual responses to pharmacological treatment. His group published the first whole-genome association study of schizophrenia, using new technology assessing hundreds of thousands of markers across the genome as well as developed a new analytic strategy to assess these data. They also initiated a collaborative research project on early-onset psychiatric disorders with James Watson, Ph.D., Codiscoverer of the DNA double helix, at Cold Spring Harbor Laboratory.
Biography Updated on 2 October 2009